Human Menopausal Gonadotropins in Combination for Stimulation does not Improve IVF Outcomes in POSEIDON Group 4 Patients, When Compared to Recombinant Follicle Stimulating Hormone Alone: A Prospective Randomized, Non-Blinded, Controlled Pilot Trial

Human Menopausal Gonadotropins in Combination for Stimulation does not Improve IVF Outcomes in POSEIDON Group 4 Patients, When Compared to Recombinant Follicle Stimulating Hormone Alone: A Prospective Randomized, Non-Blinded, Controlled Pilot Trial

Background: To evaluate whether the addition of human menopausal gonadotropin (HMG) during the early follicular phase of controlled ovarian stimulation improves clinical outcomes in patients classified as group 4 on the Patient-Oriented Strategy Encompassing IndividualizeD Oocyte Number (POSEIDON) c...

Full description

Bibliographic Details
Main Authors: Jiahui Qiu, Shan Luo, Yu Bai, Xun Zeng, Xiaohong Li
Format: Article
Language:English
Published: IMR Press 2023-11-01
Series:Clinical and Experimental Obstetrics & Gynecology
Subjects:
assisted reproduction technology
controlled ovarian stimulation
hmg
poseidon
Online Access:https://www.imrpress.com/journal/CEOG/50/11/10.31083/j.ceog5011235

Internet

https://www.imrpress.com/journal/CEOG/50/11/10.31083/j.ceog5011235

Similar Items